Todos Medical advances Tollovir™: 3CL Clinical Trials to Phase 2
October 14, 2022 14:23 ET
|
Todos Medical
Miami, Florida, United States, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Todos Medical, an in-vitro diagnostics company that develops reliable early-detection blood tests and related solutions for cancer,...
Todos Medical Enters Into $50M Contract to Supply Tollovid™ and CBD Products to Retail Distributor Company Nerd Hemp
September 22, 2022 16:02 ET
|
Todos Medical Ltd.
5500 Automated Retail Machines to be Rolled out in Q4/22 and Q1/23 $11.5M in Q4/22 Revenue Expected From This Agreement NEW YORK, NY and TEL AVIV, ISRAEL, Sept. 22, 2022 (GLOBE NEWSWIRE) -- via...
Todos Medical Partners with Amerimmune Diagnostics on Long COVID Biomarker Panel
July 28, 2022 07:30 ET
|
Todos Medical Ltd.
NEW YORK, NY, AND TEL AVIV, ISRAEL, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Releases Preliminary Data From IRB-Waived Tollovid® Market Research Study in Acute and Long COVID
June 23, 2022 07:00 ET
|
Todos Medical Ltd.
83% of Respondents With Acute COVID Were Satisfied 68% of Respondents With Long COVID Were Satisfied NEW YORK, NY, and TEL AVIV, ISRAEL, June 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire –...